Incyte Corporation INCY said Monday it has agreed to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in a deal valued at $1.25 billion upfront. The transaction will add late ...
MSN on MSN
Why Incyte (INCY) stock is up today
What Happened? Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 3.8% in the morning session after several analyst firms raised their price targets following its acquisition ...
Incyte Corporation (NASDAQ:INCY) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 22, Truist ...
Incyte's valuation still appears attractive if pipeline execution continues and analysts eventually raise long-term ...
View Incyte Corporation INCY stock quote prices, financial information, real-time forecasts, and company news from CNN.
Shares of Incyte Corp. INCY shed 1.13% to $113.36 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 7,499.36 and the ...
Feb 10 (Reuters) - Incyte Corp (INCY.O), opens new tab on Monday forecast annual sales of its skin disorder treatment Opzelura below Wall Street estimates, sending the drugmaker's shares down as much ...
(RTTNews) - Thursday, Incyte Corp. (INCY) and Genesis Therapeutics have entered into a strategic partnership focused on the research, discovery, and development of small molecule medicines. The ...
April 29 (Reuters) - Incyte Corp (INCY.O), opens new tab raised the annual sales forecast for its blood cancer drug Jakafi on Tuesday, and said it expects minimal impact from U.S. tariffs due to its ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
On Saturday, Incyte Corporation (NASDAQ:INCY) revealed results from its pivotal Phase 3 TRuE-PN clinical trial program –TRuE-PN1 and TRuE-PN2 studies – evaluating the safety and efficacy of ...
Shares of Incyte Corp. INCY slipped 1.06% to $115.62 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.72% to 7,537.43 and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results